Home -> Law Blog Directory -> Qui Tam Blogs -> False Claims Act - Qui Tam

Qui Tam

: False Claims Act - Qui Tam

Feds join whistleblower suit against Johnson & Johnson

By Phillips & Cohen LLP

The U.S. Dept. of Justice has joined a whistleblower suit alleging that pharmaceutical manufacturer Johnson & Johnson violated the False Claims Act.

The complaint alleges that J&J paid millions of dollars in kickbacks to Omnicare, the nation?s largest pharmacy specializing in dispensing drugs to nursing home patients. Omnicare had entered into an agreement with the federal government and many state governments in November 2009, paying $98 million to resolve the company's civil liability for taking kickbacks from J&J.

In its complaint against J&J, the United States alleges that the company paid kickbacks to Omnicare to induce the nursing home pharmacy company to purchase and recommend J&J drugs, including the anti-psychotic drug Risperdal, for use in nursing homes.

Full post as published by False Claims Act - Qui Tam on January 15, 2010 (boomark / email).